Clinical Trial Update: A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a Janssen investigational therapy for moderately to severely active Crohn's disease was terminated, with results posted in December 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Crohn Disease | Phase 2 | Status: TERMINATED | Results posted: 2022-12-09